allos therapeutics Pages on BioPortfolio:

Biotechnology News Allos Search
Allos Therapeutics, a biopharmaceutical company, has announced that the FDA has ... The FDA has granted orphan drug status to Allos Therapeutics pralatrexat ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - Allos Therapeutics Incorporated - Profile
View the current Allos Therapeutics Incorporated Page on BioPortfolio.com ... Allos Therapeutics is a biopharmaceutical company focused on developing and ...
http://www.bioportfolio.com/biocorporate/564-Allos+Therapeut...

Biotechnology News Allos allo. 3927147. propel. 8779. 7325. 5081 ...
Allos Therapeutics' cancer drug gets FDA's orphan designation, ... Allos Therapeutics (ALTH) Announces FDA Grants Orphan Drug Status for Pralatrexate ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

Biotechnology News Lymphoma Large-Cell Search
Allos Therapeutics' Cancer Drug Gets Orphan Drug Status .... Allos Therapeutics (ALTH) Announces FDA Grants Orphan Drug Status for Pralatrexate ...
http://www.bioportfolio.co.uk/Lymphoma%20Large-Cell-news.htm...

Biotechnology News Lymphoma Lymphoblastic doctors2. fears34 ...
Allos Therapeutics' Cancer Drug Gets Orphan Drug Status BANGALORE (Reuters) - Biopharmaceutical company Allos Therapeutics said U.S. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - @allos.com
Finance See the company profile for ALLOS THERAPEUTICS (ALTH) including ... Allos Therapeutics Incorporated - Entry on Bioportfolio's Biocorporate Database.
...
http://www.bioportfolio.com/search/@allos.com.html...

Biotechnology News Anemia Refractory romidepsin. ctcl. ptcl ...
UPDATE 1-Allos Therapeutics' cancer drug gets orphan drug status. Nov 24 ( Reuters) - Biopharmaceutical company Allos Therapeutics (nasdaq: ALTH - news ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

Biotechnology News Lymphoma T-Cell Cutaneous quik. mast. diff ...
Allos Therapeutics' cancer drug gets FDA's orphan designation, ... Nov 24 ( Reuters) - Biopharmaceutical company Allos Therapeutics (nasdaq: ALTH - news ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

Results from other life science and pharmaceutical sites:

BioSpace - Allos Therapeutics, Inc. News, Search Jobs, Events
Allos Therapeutics, Inc. 11080 CirclePoint Road, Suite 200 ... Allos Therapeutics, Inc. (ALTH) to Present at the NewsMakers in the Biotech Industry
...
http://www.biospace.com/company_profile.aspx?CompanyId=1697...

ALTH: Profile for Allos Therapeutics, Inc. - Yahoo! Finance
See the company profile for Allos Therapeutics, Inc. (ALTH) including business summary, industry/sector information, number of employees, business summary, ...
http://biz.yahoo.com/p/A/ALTH.html...

Allos Therapeutics Inc.
08:00 ET, Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, ... 16:00 ET, Allos Therapeutics Initiates Study of RH1 in
Patients with ...
http://www.prnewswire.com/gh/cnoc/comp/123129.html...

Allos Therapeutics to Report Third Quarter 2008 Results on ...
Allos Therapeutics to Report Third Quarter 2008 Results on November 5, 2008. - WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (NASDAQ: ALTH ...
http://biz.yahoo.com/bw/081029/20081029005303.html...

Scheduled Combination of Allos Therapeutics' Pralatrexate Plus ...
Scheduled Combination of Allos Therapeutics' Pralatrexate Plus Gemcitabine Proves Superior to Methotrexate Plus Cytarabine in Models of Human Non-Hodgkin's
...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

Efaproxiral Allos Therapeutics Ada Kolman
Allos Therapeutics Inc is developing the hemoglobin allosteric ..... In April 2000, Allos Therapeutics initiated a phase III, ...
http://www.biomedcentral.com/content/pdf/cd-500768.pdf...

Summary of ALLOS THERAPEUTICS INC - Yahoo! Finance
23 May 2008 ... 99.1 Press Release, dated May 23, 2008, entitled "Allos Therapeutics Announces Pricing of Public Offering of 10800000 Shares of Common Stock ...
http://biz.yahoo.com/e/080523/alth8-k.html...

Allos Therapeutics Announces Presentations on EFAPROXYN(TM) and ...
About Allos Therapeutics, Inc. Allos Therapeutics, Inc. (ALTH) is a biopharmaceutical company focused on the development and commercialization of
small ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.